Chitosan microflower-embedded gelatin sponges for advanced wound management and hemostatic applications

Int J Biol Macromol. 2024 Sep;276(Pt 1):133749. doi: 10.1016/j.ijbiomac.2024.133749. Epub 2024 Jul 9.

Abstract

The study explored the antimicrobial, antibiofilm, and hemostatic properties of chitosan microflowers (CMF) in sponge form. The main objective was to enhance the preparation of CMF by employing varying quantities of calcium chloride (CaCl2) and tripolyphosphate (TPP). CMF was then combined with gelatin (GE) in different proportions to produce three sponge samples: CMF0@GE, CMF1@GE, and CMF2@GE. The CMF had a morphology like that of a flower and produced surfaces with a porous sponge-like structure. The antibacterial activity, as determined by the zone of inhibition (ZOI), increased with greater doses of CMF. Among the tested samples, CMF2@GE had the greatest activity against Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, and Enterococcus faecium. CMF2@GE successfully suppressed biofilm formation, decreased clotting time to an average of 212.67 s, and exhibited excellent biocompatibility by preserving over 90 % viability of human skin fibroblast cells at dosages below 100 μg/mL. The results indicated that gelatin sponges filled with CMF have considerable promise as flexible medical instruments for wound healing and infection control.

Keywords: Antibacterial properties; Biocompatibility; Biofilm control; Chitosan microflowers; Hemostatic; Sponge materials; Wound dressing.

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Biofilms* / drug effects
  • Chitosan* / chemistry
  • Chitosan* / pharmacology
  • Gelatin* / chemistry
  • Hemostatics* / chemistry
  • Hemostatics* / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Wound Healing* / drug effects

Substances

  • Chitosan
  • Hemostatics
  • Gelatin
  • Anti-Bacterial Agents